Search research articles
Contact Us
Filters
Showing results (51-60 of 104) with videos related to
Page
of 11
Sort By:
Biochemistry
|
March 28, 1998
Electrostatics and the membrane association of Src: theory and experiment
D Murray, L Hermida-Matsumoto, C A Buser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2011
MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells
Kathleen A Bridges, Hiroshi Hirai, Carolyn A Buser, et al.
Journal of Molecular Biology
|
December 16, 2003
Inhibition of a mitotic motor protein: where, how, and conformational consequences
Youwei Yan, Vinod Sardana, Bei Xu, et al.
Analytical Biochemistry
|
February 22, 2001
High-performance liquid chromatography/mass spectrometry characterization of Ki4B-Ras in PSN-1 cells treated with the prenyltransferase inhibitor L-778,123
C A Buser, C J Dinsmore, C Fernandes, et al.
Bone Marrow Transplantation
|
January 8, 2013
Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT
T Daikeler, M Mauramo, A Rovó, et al.
Vox Sanguinis
|
June 19, 2013
Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention
J-P Sigle, J Thierbach, L Infanti, et al.
Gene Therapy
|
March 11, 2011
Intratumor RNA interference of cell cycle genes slows down tumor progression
S Dharmapuri, D Peruzzi, E Marra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2008
Cotreatment with vorinostat enhances activity of MK-0457 (VX-680) against acute and chronic myelogenous leukemia cells
Warren Fiskus, Yongchao Wang, Rajeshree Joshi, et al.
The Journal of Biological Chemistry
|
October 18, 1996
Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains
M Glaser, S Wanaski, C A Buser, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 20, 2002
Potent inhibitors of farnesyltransferase and geranylgeranyltransferase-I
Diem N Nguyen, Craig A Stump, Eileen S Walsh, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 104) with videos related to
Sort By:
Page
of 11
Biochemistry
|
March 28, 1998
Electrostatics and the membrane association of Src: theory and experiment
D Murray, L Hermida-Matsumoto, C A Buser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2011
MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells
Kathleen A Bridges, Hiroshi Hirai, Carolyn A Buser, et al.
Journal of Molecular Biology
|
December 16, 2003
Inhibition of a mitotic motor protein: where, how, and conformational consequences
Youwei Yan, Vinod Sardana, Bei Xu, et al.
Analytical Biochemistry
|
February 22, 2001
High-performance liquid chromatography/mass spectrometry characterization of Ki4B-Ras in PSN-1 cells treated with the prenyltransferase inhibitor L-778,123
C A Buser, C J Dinsmore, C Fernandes, et al.
Bone Marrow Transplantation
|
January 8, 2013
Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT
T Daikeler, M Mauramo, A Rovó, et al.
Vox Sanguinis
|
June 19, 2013
Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention
J-P Sigle, J Thierbach, L Infanti, et al.
Gene Therapy
|
March 11, 2011
Intratumor RNA interference of cell cycle genes slows down tumor progression
S Dharmapuri, D Peruzzi, E Marra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2008
Cotreatment with vorinostat enhances activity of MK-0457 (VX-680) against acute and chronic myelogenous leukemia cells
Warren Fiskus, Yongchao Wang, Rajeshree Joshi, et al.
The Journal of Biological Chemistry
|
October 18, 1996
Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains
M Glaser, S Wanaski, C A Buser, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 20, 2002
Potent inhibitors of farnesyltransferase and geranylgeranyltransferase-I
Diem N Nguyen, Craig A Stump, Eileen S Walsh, et al.
Page
of 11